Autobahn Therapeutics is based in San Diego, CA. It has raised $176M in total funding. Latest round: Series B.
Autobahn Therapeutics is based in San Diego, CA. Autobahn Therapeutics has raised $176M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Autobahn Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Cowen Healthcare Investments, BVF Partners L.P., Biogen, Bristol Myers Squibb, Pfizer Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Every Autobahn Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026